NASDAQ:BPMC   Blueprint Medicines Corporation
Entry price: 106.83

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 678%

- EPS % Chg (Previous Qtr): -11.64%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 8053%

- Sales % Chg (Previous Qtr): 63%

- 3-Year Sales Growth Rate: 91%

- Annual Pre -Tax Margin: -522.8%
Comment:
_________________________
- EPS % Chg (Last Qtr): -13%

- Sales % Chg (Last Qtr): -34%
Comment:
Sold at 90.47
Return: -15.31%
Comment:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.